00:00:00:00

ON-DEMAND WEBINAR

Navigating the 36‑month rule & the DME moratorium: What every DME supplier needs to know

Presented by: Barry Alexander, Office Managing Partner, Polsinelli, and Ross Sallade, Home Health, Home Care & Hospice Chair, Polsinelli
Recent regulatory changes are putting new pressure on DME organizations — especially when it comes to ownership changes, certain transactions, and operations. The expanded 36‑month change of ownership rule and the current DME moratorium are reshaping how providers plan growth, manage risk, and structure deals.

Join healthcare regulatory attorneys Barry Alexander and Ross Sallede of Polsinelli for a practical breakdown of these changes and what they mean for your DME business.

Watch Now

image description

About the speakers

Barry Alexander

Office Managing Partner

Barry Alexander is a health care regulatory and transactional attorney who advises providers, private equity sponsors and institutional investors when reimbursement mechanics, payor policy and operational structure directly impact transaction valuation, diligence and post-closing performance. He has more than 35 years of experience working in reimbursement-driven sectors where revenue integrity, compliance and valuation are closely connected. He focuses on specialized health care industries, including specialty pharmacy (infusion and compounding), behavioral health with a concentration in ABA, oncology, clinical laboratories (genetic and urine drug testing), durable medical equipment, diagnostic imaging and ophthalmology. 

Ross Sallade

Home Health, Home Care & Hospice Chair

Ross works with clients to help them navigate through the myriad of state and federal health care regulatory challenges facing them. He regularly counsels clients to aid in structuring their business transactions and relationships in compliance with federal and state regulations, including change of ownership requirements, as well as federal anti-kickback statute and federal physician self-referral (or “Stark”) laws. Ross Sallade provides value to clients by tackling the complex legal regulatory, operational, reimbursement and enrollment matters that others might be reluctant to handle. 

What you'll learn

1

How the 36‑month change of ownership rule works for DME suppliers — and when billing privileges can be blocked after a transaction

2

How the DME moratorium affects the 36‑month rule and complicates common ownership and expansion strategies

3

What the operational impacts are on routine DME activities, like location changes, acquisitions, divestitures, and internal reorganizations

Register for the on-demand webinar!


Block 1
editable text
Block 2 Top
editable text
Block 2 Bottom
editable text
grows to fill column
Block 3 Top
editable text
Block 3 Bottom
editable text
grows to fill column
Block 4
editable text
Block 1
editable text
Block 2 Top
editable text
Block 2 Bottom
editable text
grows to fill column
Block 3 Top
editable text
Block 3 Bottom
editable text
grows to fill column
Block 4
editable text

About WellSky

WellSky is a technology company leading the movement for intelligent, coordinated care worldwide. Our next-level software, analytics, and services power better outcomes and lower costs for stakeholders across the health and community care continuum. In today’s value-based care environment, WellSky helps providers, payers, health systems, and community organizations solve tough challenges, improve collaboration for growth, harness the power of data analytics, and achieve better outcomes by further connecting clinical and social care.